SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eisai to present five-year lecanemab data at CTAD 2026

BioArctic's partner Eisai is set to present five-year data for lecanemab at CTAD 2026.

Related stories